Protean PTEN: Form and function

American Journal of Human Genetics

Volumn 70, Issue 4, 2002, Pages 829-844

  Waite, Kristin A ^a   Eng, Charis ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

BREAST CANCER; CANCER RISK; CELL FUNCTION; CLINICAL FEATURE; COWDEN SYNDROME; ENDOMETRIUM CANCER; ENZYME ACTIVITY; EXON; GENE FUNCTION; GENE MUTATION; GROWTH INHIBITION; HUMAN; LIPOMATOSIS; MACROCEPHALY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THYROID CANCER; TUMOR SUPPRESSOR GENE;

PROTEA;

EID: 0036206130     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/340026     Document Type: Article

References (118)

1. Balanced translocation of 10q and 13q, including the PTEN gene, in a boy with an HCG-secreting tumor and the Bannayan-Riley-Ruvalcaba syndrome
2. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease
3. PTEN mutations are uncommon in Proteus syndrome
4. Proteus syndrome: Diagnostic criteria, differential diagnosis and patient evaluation
5. Mutations of the human PTEN gene
6. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: Evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1
7. Absence of PTEN/MMAC1 germline mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome
8. Phenotypic findings of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome in a family associated with a single germline mutation in PTEN
9. Kip1 and cyclin E/CDK2 complexes
10. Absence of germline mutations in MINPP1, a phosphatase-encoding gene centromeric of PTEN, in patients with Cowden and Bannayan-Riley-Ruvalcaba syndrome without germline PTEN mutations
11. Macrocephaly, macrosomia and autistic behavior due to a de novo PTEN germline mutation
12. Cellular survival: A play in three Akts
13. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
14. Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers
15. Hydrocephalus with features of VATER
16. Pten is essential for embryonic development and tumour suppression
17. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer
18. Mechanisms and consequences of activation of protein kinase B/Akt
19. Phospholipid signalling in the nucleus
20. Cowden syndrome
21. Genetics of Cowden syndrome: Through the looking glass of oncology
22. Will the real Cowden syndrome please stand up: Revised diagnostic criteria
23. To be or not to BMP
24. Interpretation of molecular epidemiologic research: Blinded comparison of methods for detecting germline BRCA1 mutations
25. Molecular classification of the inherited hamartoma polyposis syndromes: Clearing the muddied waters
26. Male breast cancer in Cowden syndrome patients with germline PTEN mutations
27. Protein modules as organizers of membrane structure
28. The tumor-suppressor activity of PTEN is regulated by its carboxy-terminal region
29. Expression of PTEN protein in human embryonic development
30. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors
31. Bannayan-Riley-Ruvalcaba syndrome
32. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathway
33. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay
34. Cowden syndrome
35. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
36. Localisation of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis
37. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray
38. Germline mutations of BMPR1A in juvenile polyposis
39. A gene for familial juvenile polyposis maps to chromosome 18q21.1
40. Mutations in the SMAD4/DPC4 gene in juvenile polyposis
41. Genetic heterogeneity in familial juvenile polyposis
42. VATER and hydrocephalus: Distinct syndrome?
43. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
44. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure
45. Phosphoinositol 3-kinease
46. Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer
47. The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains
48. Variant manifestation of Cowden disease in Japan: Hamartomatous polyposis of the digestive tract with mutation of the PTEN gene
49. A role for nuclear PTEN in neuronal differentiation
50. Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association
51. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor B
52. PTEN/MMAC1/TEP1 suppresses the tumorigenecity and induces G1 cell cycle arrest in human glioblastoma cells
53. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer
54. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
55. Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype
56. Cowden disease: Report of a family and review
57. Inherited mutations in PTEN that are associated with breast cancer, Cowden syndrome, and juvenile polyposis
58. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger phosphoinositol 3,4,5-triphosphate
59. Cowden syndrome (multiple hamartoma syndrome)
60. Phosphotidylinositol 3-kinase in HL-60 nuclei is bound to the nuclear matrix and increases during granulocyte differentiation
61. Germline PTEN mutations in Cowden syndrome-like families
62. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
63. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
64. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome
65. Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome (JPS)
66. The generation of lipid signaling molecules in the nucleus
67. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN
68. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
69. Agonists cause nuclear translocation of phosphotidylinositol 3-kinase γ: A Gβγ-dependent pathway that requires p110γ amino terminus
70. Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
71. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation
72. PTEN does not modulate GLUT4 translocation in rat adipose cells under physiological conditions
73. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function
74. PTEN, the tumor suppressor from human chromosome 10q23, is a dual specificity phosphatase
75. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes
76. NCCN practice guidelines: Genetics/familial high risk cancer
77. Novel PTEN mutations in patients with Cowden disease: Absence of clear genotype-phenotype correlations
78. Localization of the gene for Cowden disease to 10122-23
79. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
80. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
81. PTEN germline mutations in juvenile polyposis coli
82. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins
83. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
84. Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN
85. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells
86. Tumor suppressor PTEN inhibits nuclear accumulation of β-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation
87. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
88. A novel germline mutation of the PTEN gene in a patient with macrocephaly, ventricular dilatation and features of VATER association
89. C2 domains, structure and function of a universal C2+-binding domain
90. PTEN expression causes a feedback upregulation of IRS-2 signaling
91. Regulation of PTEN transcription by p53
92. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
93. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten +/- mice
94. The Cowden syndrome: A clinical and genetic study in 21 patients
95. Identification of a candidate turnout suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
96. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
97. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase
98. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphotidyinositol 3-kinase/Akt cell survival pathway
99. Inhibition of cell migration, spreading and focal adhesions by tumor suppressor PTEN
100. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation
101. Role of MMAC1 mutations in early onset breast cancer: Causative in association with Cowden's syndrome and excluded in BRCA1-negative cases
102. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway
103. Phosphorylation of the PTEN tail regulates protein stability and function
104. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
105. Identification of a PTEN mutation in a family with Cowden syndrome and Bannayan-Zonana syndrome
106. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies
107. PTEN coordinates G1 arrest by down regulating cyclin D1 via its protein phosphatase activity and up regulating p27 via its lipid phosphatase activity
108. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and independent pathways
109. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model
110. PTEN suppresses breast cancer cell growth by phosphatase function-dependent G1 arrest followed by apoptosis
111. PTEN expression and clinico-pathologic features in a population-based series of primary cutaneous melanoma
112. Evidence for regulation of PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAG1-2
113. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase
114. A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor
115. Association of germline mutation in the PTEN tumour suppressor gene and a subset of Proteus sand Proteus-like syndromes
116. Germline and germline mosaic mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arterio-venous malformations and lipomatosis
117. Germline mutations in BMPR1A/ALK3 cause a subset of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes
118. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome